CINECA IRIS Institutional Research Information System

FIORAVANTI, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.060
EU - Europa 1.018
AS - Asia 264
AF - Africa 39
OC - Oceania 4
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 4.392
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.009
IT - Italia 293
DE - Germania 238
SE - Svezia 166
CN - Cina 128
BG - Bulgaria 87
GB - Regno Unito 73
VN - Vietnam 53
CA - Canada 49
AT - Austria 44
TR - Turchia 40
FI - Finlandia 33
CI - Costa d'Avorio 25
FR - Francia 23
UA - Ucraina 21
BE - Belgio 18
IN - India 18
SG - Singapore 13
NG - Nigeria 8
HK - Hong Kong 6
NL - Olanda 6
RU - Federazione Russa 6
SN - Senegal 6
AU - Australia 4
DK - Danimarca 4
CH - Svizzera 3
BR - Brasile 2
JP - Giappone 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CL - Cile 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EU - Europa 1
GS - Georgia del Sud e Isole Sandwich Australi 1
IE - Irlanda 1
MX - Messico 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 4.392
Salva come PNG Salva come JPEG
Città #
Woodbridge 425
Ann Arbor 408
Fairfield 384
Houston 318
Chandler 222
Seattle 182
Ashburn 179
Wilmington 170
Cambridge 138
Serra 132
Sofia 87
Beijing 58
New York 56
Ottawa 47
Vienna 43
Dong Ket 39
Des Moines 36
Izmir 36
Princeton 36
Medford 35
Lawrence 34
Dearborn 26
Falls Church 26
Abidjan 25
Rho 19
Boulder 18
Brussels 18
Nanjing 18
Jacksonville 17
San Diego 16
Florence 15
Nürnberg 15
London 14
Bremen 12
Nanchang 11
Pune 11
Seacroft 11
Frankfurt am Main 10
Milan 10
Düsseldorf 9
Lagos 8
Redwood City 8
Shenyang 8
Boardman 7
Los Angeles 7
Marseille 7
Pisa 7
Dakar 6
Hong Kong 6
Lancaster 6
Norwalk 5
Changsha 4
Indiana 4
San Francisco 4
Shanghai 4
Auburn Hills 3
Copenhagen 3
Hefei 3
Jiaxing 3
Kunming 3
Ogden 3
Phoenix 3
Tianjin 3
Amsterdam 2
Chengdu 2
Groningen 2
Hebei 2
Jüchen 2
Kocaeli 2
La Canada Flintridge 2
Massa 2
Melbourne 2
Positano 2
Simi Valley 2
São Paulo 2
Tappahannock 2
Washington 2
Alexandria 1
Atlanta 1
Bandar Seri Begawan 1
Bern 1
Buffalo 1
Canberra 1
Casoria 1
Cecina 1
Council Bluffs 1
Delhi 1
Dublin 1
Edinburgh 1
Fremont 1
Gallicano 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Istanbul 1
Kolkata 1
Lanzhou 1
Lettomanoppello 1
Lucca 1
Mcallen 1
Totale 3.532
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 313
VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration 189
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. 186
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. 181
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab. 165
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 160
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 159
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 151
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers 143
The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. 139
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 139
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 138
Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients 135
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine 135
Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration. 133
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 120
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer 113
Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo. 113
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 112
Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasis. 108
Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: evaluation of the effects of switched schedules and related pharmacodynamics 105
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists 104
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells 102
The effect of osteogenic growth peptide (OGP) on proliferation and adhesion of HEMC-1 human endothelial cells 101
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer 101
null 101
Derivati a nucleo pirazolo[3,4-d]pirimidinico quali inibitori di proteine tirosina chinasi 99
Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells 99
Metronomic cyclophosphamide in elderly patients with advanced, castration-resistant prostate cancer 95
Overexpression and functional relevance of somatostatin receptor-1, -2, and -5 in endometrium and endometriotic lesions 92
null 89
Vascular endothelial growth factor levels in immunodepleted plasma of cancer patients as a possible pharmacodynamic marker for bevacizumab activity. 83
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients 79
A new biometric tool for three-dimensional subcutaneous tumor scanning in mice. 73
Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1 72
Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients 35
VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide. 25
Totale 4.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.165
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019371 0 0 0 0 0 0 0 0 0 117 150 104
2019/20201.081 107 83 80 115 105 119 117 92 110 65 69 19
2020/2021460 57 54 46 19 30 22 7 48 36 51 26 64
2021/2022473 10 41 20 14 76 65 16 21 25 26 22 137
2022/2023652 85 99 60 74 66 89 3 37 105 2 29 3
2023/2024201 21 18 27 5 26 64 9 20 5 6 0 0
Totale 4.487